Approval · Notice of Compliance 12101 · 2011
DIPROSALIC: Notice of Compliance 12101
Issued February 22, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12101
- Date
- February 22, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid / Keratolytic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPROSALIC | 00578428 | Cancelled Post Market |
| DIPROSALIC | 00578436 | Marketed |
Medicinal ingredients
- BETAMETHASONE DIPROPIONATE 0.5 MG per G
- SALICYLIC ACID 20 MG per G
- SALICYLIC ACID 30 MG per G